Ir & Press

Below you will find the latest news from Olerup SSP. For further information please contact Anders Karlsson, CEO of Olerup SSP.


CareDx exclusively distributing TruSight HLA

2018-05-09

On May 4, CareDx and Illumina entered into a commercial agreement which provides CareDx with the exclusive global distribution rights for TruSight HLA

Olerup QTYPE® receives CE/IVD certification

2018-04-13

CareDx, Inc. (NASDAQ:CDNA), a molecular diagnostics company focused on the discovery, development, and commercialization of clinically differentiated, high-value diagnostic solutions for transplant patients, announced today that Olerup QTYPE, the fastest real time Human Leukocyte Antigen (HLA) typing diagnostic, has received CE Mark approval.

Olerup QTYPE® now available on Applied Biosystems® platforms

2018-03-18

Olerup QTYPE provides tissue typing laboratories with the most suitable product for real time HLA typing of donors and recipients of organ transplants. The workflow is simple and the test is performed within one hour, faster than any other available product on the market. Olerup QTYPE has previous been available on the Roche LightCycler® 480 II and now the Applied Biosystems platforms QuantStudio™ 6, 7 and ViiA™ 7 are also supported. To further facilitate labs to start using real time PCR in HLA typing, CareDx has also signed an agreement to be able to sell these ABI instruments through its sales channels. For more information on Olerup QTYPE, please click on the Product tab above or contact your CareDx representative. Olerup QTYPE is for research use only

CareDx to launch new Olerup web page

2017-03-07

CareDx today launched the new web page for its pre-transplant Olerup Brands

Olerup and Qiagen agree upon a new Joint Improvement Program

2016-05-31

Olerup and Qiagen have recently agreed upon a new Joint Improvement Program of the QIAxcel® Advanced System for Olerup SSP® data generation and automatic data transferal into the Olerup version of Helmberg-SCORE™.

CareDx Completes Allenex Acquisition

2016-04-14

Expands Product Offerings to Support Transplant Patients BRISBANE, CA, April 14, 2016: CareDx, Inc. (Nasdaq: CDNA), a molecular diagnostics company focused on the discovery, development and commercialization of clinically differentiated, high-value diagnostic surveillance solutions for transplant patients, today announced the completion of its previously announced acquisition of Allenex AB. The combination of CareDx and Allenex creates an international transplant diagnostics company with product offerings focused on transplantation. The combined organization will have a direct presence in the United States and Europe supported by a broad global distributor network.

Meet us at EFI

2016-03-29

Olerup will exhibit its bench mark products during the EFI meeting at Kos, Greece, starting on May 11.

Olerup, Platinum Sponsor at the upcoming EFI Meeting

2015-04-01

Olerup will be present as Platinum Sponsor at the annual EFI Meeting held in Geneva starting April 27, 2015

Olerup Platinum Sponsor at the upcoming EFI meeting

2014-06-24

Olerup will be Platinum Sponsor at the EFI Meeting held in Stockholm starting June 25. Olerup will present their existing Product line as well as new Products coming from the extended collaboration with its partner, Conexio Genomics from Australia.

Olerup to present at the upcoming APHIA meeting in Hong Kong

2013-05-23

Olerup, a leading company within the field of transplant diagnostics, will be present at the upcoming APHIA meeting in Hong Kong, July 30 - Aug 2. At the meeting Olerup will present the pioneering HLA typing product lines for SSP (Olerup SSP) and SBT (SBT Resolver of Conexio).